Literature DB >> 15009466

Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics.

K Vanschoonbeek1, M A H Feijge, R J W Van Kampen, H Kenis, H C Hemker, P L A Giesen, J W M Heemskerk.   

Abstract

The hemostatic activity of plasma is determined by platelet activation and coagulation, which processes are mutually stimulatory. We studied this interaction by measuring the cleavage of fluorescent thrombin substrate in platelet-rich plasma (PRP), using the calibrated thrombogram method. In freshly isolated human plasma, thrombin formation triggered by tissue factor was fully dependent on the presence of platelets. It was abolished by annexin A5, indicating dependence on phosphatidylserine (PS) exposure at activated platelets. Comparison of plasmas from various subjects showed considerable interindividual variation in total amount of thrombin generation, regardless of whether platelets or PS-containing phospholipids were present. Integrin alphaIIbbeta3 antagonists and ADP receptor blockage, but not aspirin, decreased the rate of thrombin generation (thrombin peak level) and extended the time of onset. Platelet inhibition with cAMP-elevating agents decreased the thrombin-forming rate, but surprisingly shortened the onset time. Stimulation of platelets with agonists of Gi/q-coupled receptors and, to a larger extent, with collagen or Ca2+-ionophore increased the rate of thrombin generation and shortened its onset. In PRP from donors with low and high generation, platelet inhibitors and activators were similarly effective. Taken together, these results indicate that, in tissue factor-triggered PRP, PS exposure on activated platelets regulates both onset and rate of thrombin generation. However, coagulant activity rather than platelet activation determines the total amount of thrombin formed, i.e. the endogenous thrombin potential. Thus, kinetics of thrombin generation in PRP are controlled by platelet inhibitors and agonists, but the process is restricted in amount by the subject-dependent variation in coagulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009466     DOI: 10.1111/j.1538-7933.2004.00618.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  24 in total

1.  Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow.

Authors:  Judith M E M Cosemans; Saskia E M Schols; Lucia Stefanini; Susanne de Witt; Marion A H Feijge; Karly Hamulyák; Hans Deckmyn; Wolfgang Bergmeier; Johan W M Heemskerk
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

2.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; James H Morrissey; George L Dale; Paul Friese; Naomi L Esmon; Charles T Esmon
Journal:  Blood       Date:  2011-06-14       Impact factor: 22.113

4.  A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?

Authors:  Claire Pluchart; Coralie Barbe; Gael Poitevin; Sandra Audonnet; Philippe Nguyen
Journal:  J Thromb Thrombolysis       Date:  2020-11-28       Impact factor: 2.300

5.  Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.

Authors:  Anton A Vrij; Ardi Oberndorff-Klein-Woolthuis; Gerard Dijkstra; Andrea E de Jong; Rob Wagenvoord; Hendrik C Hemker; Reinhold W Stockbrügger
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

6.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques.

Authors:  Reyhan Nergiz-Unal; Judith M E M Cosemans; Marion A H Feijge; Paola E J van der Meijden; Robert F Storey; J J J van Giezen; Mirjam G A oude Egbrink; Johan W M Heemskerk; Marijke J E Kuijpers
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

8.  Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Authors:  Kellie R Machlus; Emily A Colby; Jogin R Wu; Gary G Koch; Nigel S Key; Alisa S Wolberg
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

9.  Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction.

Authors:  Oliver Borst; Patrick Münzer; Nada Alnaggar; Sascha Geue; Roland Tegtmeyer; Dominik Rath; Michal Droppa; Peter Seizer; Stefan Heitmeier; Johan W M Heemskerk; Lisa K Jennings; Robert F Storey; Dominick J Angiolillo; Bianca Rocca; Henri Spronk; Hugo Ten Cate; Meinrad Gawaz; Tobias Geisler
Journal:  Blood Adv       Date:  2018-03-27

10.  Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.

Authors:  Robert S Poston; Junyan Gu; Charles White; Jean Jeudy; Lei Nie; James Brown; James Gammie; Richard N Pierson; Linda Romar; Bartley P Griffith
Journal:  Transfusion       Date:  2008-03       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.